Yale tests microdosing for brain boost
NCT ID NCT07449351
First seen Mar 09, 2026 · Last updated May 01, 2026 · Updated 7 times
Summary
This early-phase study at Yale will give 20 healthy adults who have never used psychedelics either a very low (micro) dose of psilocybin or a placebo over 30 days. Researchers will measure changes in mood, memory, and brain scans to see if microdosing can improve well-being without causing a psychedelic experience. The goal is to gather initial data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Olin Neuropsychiatry Research Center
Hartford, Connecticut, 06106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.